Drug
Freshly manufactured 35 kDa hyaluronan fragment
Freshly manufactured 35 kDa hyaluronan fragment is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Local Injection of Periodontal Pocket Method for the Treatment of Gingivitis
NCT05812300
completednot_applicable
Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds
NCT05810649
completednot_applicable
Injection Therapy for Neuropathic Pain
NCT05809700
Clinical Trials (3)
Showing 3 of 3 trials
NCT05812300Not Applicable
Local Injection of Periodontal Pocket Method for the Treatment of Gingivitis
NCT05810649Not Applicable
Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds
NCT05809700Not Applicable
Injection Therapy for Neuropathic Pain
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3